- The trend backdrop is active with a 5-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
RENX
LSE
Week ended 02 Oct 2026
Weekly Investor Report
Renalytix Plc · Healthcare · Health Information Services
Latest close
0.06 GBP
-2.4%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 99.7% above the Trend Line and sits at 52.4% of its 52-week range. The latest completed week returned -2.4%, after a 44.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100.
Setup score
58
out of 100
Latest Close
0.06 GBP
2 Oct 2026
1W Return
-2.4%
latest completed week
4W Return
44.6%
short-term follow-through
12W Return
114.3%
quarterly tape
Trend Breadth
15.4%
8 of 52 weeks active
Volume Ratio
1.7x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 24.15% based on similar historical setup states.
- The share remains more than 20% below its 52-week high.
- Recent volatility is running well above the one-year baseline.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-2.4%
Latest completed week; four-week move 44.6%.
Indicator stack
26/86
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 24.15%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
11 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 99.7% above the Trend Line and sits at 52.4% of its 52-week range. The latest completed week returned -2.4%, after a 44.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.7x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
21 Aug
28 Aug
4 Sep
11 Sep
18 Sep
25 Sep
2 Oct
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.7112-week average 0.38
12-week confirmation
Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership4/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.71Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 44.6% over four weeks, 114.3% over 12 weeks, and -30.6% over one year. The current trend has remained active for 5 consecutive weeks.
Performance by holding period
Active trend streak5 weeks
Active weeks in one year8
Trend breadth15.4%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.85Latest activity-pressure read.
Pressure change35.7%Four-week change in activity pressure.
Leadership31.85Latest relative-leadership reading.
RS change285.4%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 25 Sep 2026
Financial statements through 30 Jun 2025
Field coverage 64%
Model confidence 28%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength32/100Blend of value, momentum, and quality. Underlying universe rank 69; rank 1 is best.
Value37/100Relative valuation strength. Underlying universe rank 64; rank 1 is best.
Quality38/100Profitability and accounting quality. Underlying universe rank 63; rank 1 is best.
Momentum37/100Medium-term price momentum. Underlying universe rank 64; rank 1 is best.
Growth37/100Revenue and earnings growth. Underlying universe rank 64; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- - Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- - Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 40.0% Gross profit retained from each unit of revenue.
- Operating margin
- -573.3% Operating profit retained from revenue.
- Free-cash-flow margin
- -596.7% Free cash flow generated from revenue.
- Return on invested capital
- - Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 30.4% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 5/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- - Net share repurchases relative to market value.
- Shareholder yield
- - Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 0.0x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 11 relevant articles.
4 positive · 6 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-40.0%Distance below the 52-week high.
13-week volatility17.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
10 Apr
8 May
5 Jun
3 Jul
31 Jul
28 Aug
2 Oct
Weeks higher8 of 269 weeks finished lower.
Best week+51.8%Week of 11 Sep.
Worst week-6.1%Week of 21 Aug.
Latest week-2.4%Week of 2 Oct.
Shape of recent returns
Strong gains6
Modest gains2
Flat weeks9
Modest losses6
Sharp losses3
Recent vol17.4%13-week weekly-return volatility.
Base vol12.1%52-week weekly-return volatility.
Up/down split11/25Count of positive and negative weeks in the 52-week window.
Average skew15.6% / -7.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorGB Healthcare
4-week rank1 / 78
Group average-2.2%
Trend breadth32.1%
Trend32.1%active weekly trend signals
MD57.7%positive activity pressure
RS32.1%positive relative leadership
Four-week leaders
IndustryGB Health Information Services
4-week rank1 / 9
Group average11.2%
Trend breadth66.7%
Trend66.7%active weekly trend signals
MD88.9%positive activity pressure
RS66.7%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape52/100
Trend, activity pressure, participation, and risk combine to a 52/100 tape read.
Indicator analysis59/100Latest 12-week confirmation: trend 5/12, activity pressure 12/12, relative leadership 4/12.
Activity pressure 0.71; No reversal markers Next-Week ExpectancyNegative 24.15%Next-week expectancy is negative with a 24.15% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors35/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 50 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 11 relevant articles.
RENX Forecast — Price Target — Prediction for 2027 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 2 Oct 2026 | 0.06 GBP | -2.4% | 0.03 GBP | 0.1143 GBP | 1.85 | 31.85 | 8.3M | On |
| 25 Sep 2026 | 0.0615 GBP | -1.6% | 0.0292 GBP | 0.1169 GBP | 1.75 | 30.25 | 2.8M | On |
| 18 Sep 2026 | 0.0625 GBP | -0.8% | 0.0283 GBP | 0.1204 GBP | 1.67 | 30.09 | 11.2M | On |
| 11 Sep 2026 | 0.063 GBP | 51.8% | 0.0275 GBP | 0.1255 GBP | 1.51 | 28.07 | 30.2M | On |
| 4 Sep 2026 | 0.0415 GBP | 0.0% | 0.0268 GBP | 0.1306 GBP | 1.36 | -17.18 | 0 | On |
| 28 Aug 2026 | 0.0415 GBP | 7.8% | 0.0274 GBP | 0.1367 GBP | 1.44 | -17.98 | 55.0K | Off |
| 21 Aug 2026 | 0.0385 GBP | -6.1% | 0.0279 GBP | 0.1438 GBP | 1.32 | -24.64 | 131.2K | Off |
| 14 Aug 2026 | 0.041 GBP | 10.8% | 0.0287 GBP | 0.1506 GBP | 1.22 | -20.10 | 293.9K | Off |
| 7 Aug 2026 | 0.037 GBP | 39.6% | 0.0294 GBP | 0.1566 GBP | 1.16 | -29.60 | 3.9M | Off |
| 31 Jul 2026 | 0.0265 GBP | 0.0% | 0.0303 GBP | 0.1633 GBP | 0.99 | -50.39 | 102.4K | Off |
| 24 Jul 2026 | 0.0265 GBP | -3.6% | 0.0313 GBP | 0.17 GBP | 0.95 | -50.90 | 162.6K | Off |
| 17 Jul 2026 | 0.0275 GBP | -1.8% | 0.0324 GBP | 0.177 GBP | 0.84 | -49.45 | 3.8M | Off |
| 10 Jul 2026 | 0.028 GBP | 21.7% | 0.0336 GBP | 0.1852 GBP | 0.61 | -49.07 | 810.0K | Off |
| 3 Jul 2026 | 0.023 GBP | 21.1% | 0.0347 GBP | 0.1937 GBP | 0.39 | -59.64 | 259.8K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.